Anti-inhibitor coagulant complex Disease Interactions
There is 1 disease interaction with anti-inhibitor coagulant complex:
Anti- inhibitor coagulation (Includes anti-inhibitor coagulant complex) ↔ thrombo/hemorrhage
Severe Potential Hazard, High plausibility. Applies to: History - Thrombotic/Thromboembolic Disorder, Thrombotic/Thromboembolic Disorder, Disseminated Intravascular Coagulation, Myocardial Infarction, Pulmonary Embolism
The use of anti- inhibitor coagulant complex is contraindicated in patients with significant signs of fibrinolysis, disseminated intravascular coagulation (DIC), and acute thrombosis or embolism including myocardial infarction. Anti- inhibitor coagulant complex contains Factor VIII inhibitor bypassing activity and prothrombin complex factors and may cause or exacerbate fibrinolysis or coagulation. If DIC or fibrinolysis occurs during treatment, the infusion should be stopped promptly and appropriate therapeutic measures initiated. Thromboembolic events may also occur during treatment, particularly following the administration of large doses and/or in patients with thrombotic risk factors. Caution is advised when administering anti- inhibitor coagulant complex to patients with an active or past history of thromboembolic disorders.
- "Product Information. Autoplex T (anti-inhibitor coagulant complex)." Nabi, Boca Raton, FL.
Anti-inhibitor coagulant complex drug interactions
There are 5 drug interactions with anti-inhibitor coagulant complex
More about anti-inhibitor coagulant complex
- Anti-inhibitor coagulant complex Side Effects
- Dosage Information
- Drug Interactions
- En Español
- Drug class: miscellaneous coagulation modifiers
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.